You are here

A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

Last updated on February 17, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Overland Park, Kansas, 66211 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-85 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- For Healthy adult volunteers: healthy male and/or female subjects of non child bearing
potential between the ages of 18 and 55 years, inclusive. (Healthy is defined as no
clinically relevant abnormalities identified by a detailed medical history, full
physical examination, including blood pressure and heart rate measurement, 12 lead ECG
and clinical laboratory tests.)

- For Healthy Elderly volunteers: healthy male and/or female subjects of non child
bearing potential between the ages of 65 and 85 years, inclusive. Subjects must be in
reasonably good health as determined by the investigator based on a detailed medical
history, full physical examination (including blood pressure and pulse rate
measurement), 12 lead ECG and clinical laboratory tests. Subjects with mild, chronic,
stable disease (eg, controlled hypertension, non-insulin dependent diabetes,
osteoarthritis) may be enrolled if deemed medically prudent by the investigator. In
order to ensure an age range relevant to the Alzheimer's Disease (AD) population, no
more than 30% of subjects enrolled in any cohort may be less than 70 years of age.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence or history of clinically significant hematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or
allergic disease (including drug allergies, but excluding untreated, asymptomatic,
seasonal allergies at time of dosing).

NCT01169714
Pfizer
Completed
A Study To Observe Safety And Blood Concentrations Of PF-04995274 During And Following the Administration of Multiple Doses Of PF-04995274 In Healthy Adult And Healthy Elderly Volunteers.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Healthy
NCT01549574
All Genders
18+
Years
Bruxelles,
Healthy, Long QT Syndrome
NCT00316459
All Genders
18+
Years
Miami, Florida
Healthy
NCT01448395
Males
30+
Years
Ruddington, Nottingham
Healthy
NCT02531815
Males
18+
Years
Brussels,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now